NCT00925470已完成不适用
Evaluation of Target Organs Impairment on Patients Suffering From High Blood Pressure Without Known Cardio Vascular or Renal Disease, Stratified on Blood Pressure Control.
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- AstraZeneca
- 入组人数
- 1,200
- 试验地点
- 1
- 主要终点
- To evaluate the frequency of evaluation of target organs preclinical impairment on patients without known cardiovascular or renal disease, taking into consideration the blood pressure level (controlled HBP or not)
研究概览
简要总结
Evaluation of target organs impairment on patients suffering from high blood pressure without known cardio vascular or renal disease, stratified on blood pressure control.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Cross Sectional
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Adults with hypertension (treated or not), without known cardiovascular or renal disease.
排除标准
- 未提供
结局指标
主要结局
To evaluate the frequency of evaluation of target organs preclinical impairment on patients without known cardiovascular or renal disease, taking into consideration the blood pressure level (controlled HBP or not)
时间窗: Once
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Evaluation of Target Organs Damage in Hypertensive PatientsTarget Organs DamageHypertensiveno Known Cardiovascularno Known Renal DiseaseNCT01055353AstraZeneca1,857
已完成
不适用
Target Organ Damage and Polymorphisms Vav-2 and Vav-3 in Hypertensive SubjectsHypertensionNCT02022618Fundacion para la Investigacion y Formacion en Ciencias de la Salud454
Unknown
不适用
Central Hemodynamic and Sodium UrinaryHypertensionNCT03932422Hospital de Base100
已完成
不适用
Positive Care Effect of the Digital Health Assistant ADELE Blood Pressure for Hypertension PatientsEssential (Primary) HypertensionHypertensive Heart Disease With (Congestive) Heart FailureHypertensive Heart Disease Without (Congestive) Heart FailureOther Secondary HypertensionSecondary Hypertension, UnspecifiedSyncope and CollapseDizziness and GiddinessNCT06663280Alma Phil Gmbh108
已完成
4 期
Nijmegen Antihypertensive Management Improvement StudyPrimary HypertensionNCT00457483Radboud University Medical Center120